Jundong Wu
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chidamide Combined With Angiogenesis Inhibitors and Fulvestrant for Advanced HR-positive, HER2-negative Breast Cancer (NCT06750848) | Jundong Wu | 2024-12-20 |
Track Jundong Wu automatically
Every clearance here is in the API, with alerts when new ones post.